Year |
Citation |
Score |
2021 |
Olsson Hau S, Wahlin S, Cervin S, Falk V, Nodin B, Elebro J, Eberhard J, Moran B, Gallagher WM, Karnevi E, Jirström K. PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer. The Journal of Pathology. Clinical Research. PMID 34379360 DOI: 10.1002/cjp2.238 |
0.301 |
|
2020 |
Wilkinson M, Sinclair P, Dellatorre-Teixeira L, Swan P, Brennan E, Moran B, Wedekind D, Downey P, Sheahan K, Conroy E, Gallagher WM, Docherty N, Roux CL, Brennan DJ. The Molecular Effects of a High Fat Diet on Endometrial Tumour Biology. Life (Basel, Switzerland). 10. PMID 32927694 DOI: 10.3390/Life10090188 |
0.321 |
|
2020 |
Silva R, Moran B, Russell NM, Fahey C, Vlajnic T, Manecksha RP, Finn SP, Brennan DJ, Gallagher WM, Perry AS. Evaluating liquid biopsies for methylomic profiling of prostate cancer. Epigenetics. 1-13. PMID 32000564 DOI: 10.1080/15592294.2020.1712876 |
0.329 |
|
2020 |
O'Connor DP, Walsh L, Haley K, Moran B, Mooney B, Madden S, Das S, Rueda O, Dowling C, Vareslija D, Chin S, Linn S, Young L, Jirstrom K, Crown JP, et al. Abstract P3-10-06: Combination of BET and FGFR inhibition as a rational therapeutic strategy for invasive lobular breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-10-06 |
0.352 |
|
2019 |
Walsh L, Haley KE, Moran B, Mooney B, Tarrant F, Madden SF, Di Grande A, Fan Y, Das S, Rueda OM, Dowling CM, Varešlija D, Chin SF, Linn SC, Young LS, et al. BET inhibition as a rational therapeutic strategy for invasive lobular breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31409615 DOI: 10.1158/1078-0432.Ccr-19-0713 |
0.319 |
|
2019 |
Cox OT, Edmunds SJ, Simon-Keller K, Li B, Moran B, Buckley NE, Bustamante-Garrido M, Healy N, O'Flanagan CH, Gallagher WM, Kennedy RD, Bernards R, Caldas C, Chin SF, Marx A, et al. PDLIM2 is a marker of adhesion and β-catenin activity in triple-negative breast cancer. Cancer Research. PMID 30885980 DOI: 10.1158/0008-5472.Can-18-2787 |
0.337 |
|
2019 |
Haley K, Walsh L, Moran B, Das S, Tarrant F, Caldas C, Bernards R, Gallagher W, O'Connor D, Chonghaile TN. Abstract PD7-01: Bromodomain protein 3 is a novel therapeutic target in invasive lobular carcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Pd7-01 |
0.339 |
|
2019 |
O'Connor D, Mooney B, Das S, Klinger R, Moran B, Chonghaile TN, Cagney G, Bracken A, Gallagher W. Abstract P5-05-07: Expression of the cocaine- and amphetamine-regulated transcript (CART) recruits SWI/SNF chromatin remodelling complexes to the estrogen receptor Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-05-07 |
0.365 |
|
2019 |
Brennan DJ, Naicker K, Das S, Moran B, Klinger R, Ponten F, Hewitt S, Jirström K, Byrne AT, O'Sullivan J, Gallagher WM, O'Connor DP. Abstract 5033: The role of the epigenetic regulator SATB2 in colon cancer progression Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5033 |
0.35 |
|
2019 |
Russell-Hallinan A, Glezeva N, Moran B, Das S, Ledwidge M, McDonald K, Baugh J, Watson C. 36 Hypoxia induces gene-specific epigenetic modifications that promotes a hyperactive pro-fibrotic phenotype in human cardiac fibroblasts Heart. DOI: 10.1136/Heartjnl-2019-Ics.36 |
0.303 |
|
2019 |
Russell-Hallinan A, Glezeva N, Moran B, Das S, Baugh J, Watson C. BS40 Hypoxia induces gene-specific epigenetic modifications in human cardiac fibroblasts Heart. 105. DOI: 10.1136/Heartjnl-2019-Bcs.202 |
0.323 |
|
2019 |
Glezeva N, Moran B, Collier P, Moravec C, Phelan D, Donnellan E, Russell-Hallinan A, O'connor D, Gallagher W, Gallagher J, McDonald K, Ledwidge M, Baugh J, Das S, Watson C. 3069Epigenetic changes in heart failure cohorts: novel insights into methylation changes of protein and RNA coding genes in human cardiac tissue European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz745.0025 |
0.33 |
|
2018 |
Das S, Moran B, Perry AS. Assessing DNA Methylation in Cancer Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1692: 157-178. PMID 28986896 DOI: 10.1007/978-1-4939-7401-6_15 |
0.332 |
|
2018 |
Hau SO, Karnevi E, Lundgren S, Li B, Lynch S, Elebro J, Heby M, Nodin B, Eberhard J, Uhlén M, Moran B, Gallagher WM, Jirstrom K. A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes. Journal of Clinical Oncology. 36: 305-305. DOI: 10.1200/Jco.2018.36.4_Suppl.305 |
0.398 |
|
2018 |
Barat A, Smeets D, Moran B, Das S, Betge J, Murphy V, Kay E, Grieken NCTv, Verheul HMW, Gaiser T, Ebert MP, Schulte N, Hennessy B, Gallagher WM, McNamara DA, et al. A machine-learning approach for the identification of highly predictive germline SNPs as biomarkers for response to bevacizumab in metastatic colorectal cancer using Elastic Net and Lasso. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E15584 |
0.319 |
|
2018 |
O'Connor D, Brennan DJ, Naicker K, Das S, Moran B, Klinger R, Ponten F, Hewitt SM, Jirstrom K, Byrne AT, O'Sullivan J, Gallagher WM. SATB2 loss and the immune milieu of colorectal cancer (CRC). Journal of Clinical Oncology. 36: 3569-3569. DOI: 10.1200/Jco.2018.36.15_Suppl.3569 |
0.345 |
|
2018 |
Dwane L, Das S, Moran B, O'Connor A, Mulrane L, Dirac A, Jirstrom K, Crown J, Bernards R, Gallagher W, Chonghaile TN, O'Connor D. Abstract P2-05-02: Functional genomic screening identifies ubiquitin-specific protease 11 (USP11) as a novel regulator of ER-alpha transcription in breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P2-05-02 |
0.319 |
|
2017 |
Moran B, Silva R, Perry AS, Gallagher WM. Epigenetics of Malignant Melanoma. Seminars in Cancer Biology. PMID 29074395 DOI: 10.1016/J.Semcancer.2017.10.006 |
0.319 |
|
2017 |
Moran B, Das S, Smeets D, Peutman G, Klinger R, Fender B, Connor K, Ebert M, Gaiser T, Prehn JH, Bacon O, Kay E, Hennessy B, Murphy V, Ylstra B, et al. Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach. Oncotarget. PMID 28611295 DOI: 10.18632/Oncotarget.18296 |
0.319 |
|
2017 |
Moran B, Rahman A, Palonen K, Lanigan FT, Gallagher WM. Master Transcriptional Regulators in Cancer: Discovery via Reverse Engineering Approaches and Subsequent Validation. Cancer Research. PMID 28428271 DOI: 10.1158/0008-5472.Can-16-1813 |
0.366 |
|
2017 |
Moran B, Lanigan F, Russell N, Barron S, Wang C, Jirstrom K, Bracken AP, Gallagher WM. Evaluation of the prognostic value of the OncoMasTR RNA panel in diverse tumor types. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E23201 |
0.317 |
|
2017 |
Keegan NM, Toomey S, Fay J, Madden SF, Moran B, Milewska M, Das S, O'Connor D, Kennedy MJ, Power C, Hill AD, Egan K, Teiserskiene A, Kay E, Crown J, et al. Effect of TCHL-based therapy on immune cell content in on-treatment, neoadjuvant-treated HER2-positive breast cancer patients. Journal of Clinical Oncology. 35: 583-583. DOI: 10.1200/Jco.2017.35.15_Suppl.583 |
0.312 |
|
2017 |
Byrne AT, Smeets D, Miller IS, Das S, Boeckx B, Depreeuw J, Gaiser T, Betge J, Barat A, Murphy V, Moran B, Fender B, Klinger R, Ebert MP, Grieken NCTv, et al. Identification of a novel predictive genomic biomarker for response to combination bevacizumab in metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 35: 3580-3580. DOI: 10.1200/Jco.2017.35.15_Suppl.3580 |
0.346 |
|
2017 |
Walsh L, Moran B, Das S, Tarrant F, Schouten P, Chin S, Bernards R, Caldas C, Gallagher W, Chonghaile TN, O'Connor D. Abstract 4674: Epigenetic modulators for the treatment of invasive lobular carcinoma breast cancer Cancer Research. 77: 4674-4674. DOI: 10.1158/1538-7445.Am2017-4674 |
0.351 |
|
2017 |
O'Connor DP, Das S, Kelly D, Moran B, Han K, Mulligan N, Barrett C, Buckley P, McMahon P, McCaffrey J, Essen Hv, Connor K, Ylstra B, Lambrechts D, Gallagher WM, et al. Abstract 3397: Post-mortem examination of an aggressive case of medullary thyroid cancer characterised by catastrophic genomic abnormalities Cancer Research. 77: 3397-3397. DOI: 10.1158/1538-7445.Am2017-3397 |
0.301 |
|
2017 |
Glezeva N, Das S, Moran B, Ledwidge M, McDonald K, Baugh J, Watson C. 63 Hypoxia induces gene-specific epigenetic modifications in human cardiac fibroblasts which are associated with the development of myocardial fibrosis Heart. 103. DOI: 10.1136/Heartjnl-2017-Ics17.62 |
0.328 |
|
2016 |
Burke L, Butler CT, Murphy A, Moran B, Gallagher WM, O'Sullivan J, Kennedy BN. Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer. Frontiers in Cell and Developmental Biology. 4: 103. PMID 27709113 DOI: 10.3389/Fcell.2016.00103 |
0.321 |
|
2016 |
Moran B, Cummins SB, Creevey CJ, Butler ST. Transcriptomics of liver and muscle in Holstein cows genetically divergent for fertility highlight differences in nutrient partitioning and inflammation processes. Bmc Genomics. 17: 603. PMID 27514375 DOI: 10.1186/S12864-016-2938-1 |
0.563 |
|
2016 |
Das S, Moran B, Smeets D, Peuteman G, Klinger R, Fender B, Connor K, Ebert M, Gaiser T, Prehn J, Bacon O, Kay E, Hennessy B, Murphy V, Gallagher W, et al. Abstract 4529: Tailoring approaches for global epigenome analysis from archival formalin-fixed paraffin-embedded tissue samples Cancer Research. 76: 4529-4529. DOI: 10.1158/1538-7445.Am2016-4529 |
0.315 |
|
2016 |
Connor K, Das S, Moran B, Mulrane L, Gallagher WM, O’Connor D. Abstract 2771: Epigenetic regulation of the cocaine and amphetamine regulated transcript (CART) in cancer Cancer Research. 76: 2771-2771. DOI: 10.1158/1538-7445.Am2016-2771 |
0.395 |
|
2015 |
Moran B, Butler ST, Moore SG, MacHugh DE, Creevey CJ. Differential gene expression in the endometrium reveals cytoskeletal and immunological genes in lactating dairy cows genetically divergent for fertility traits. Reproduction, Fertility, and Development. PMID 26304020 DOI: 10.1071/Rd15128 |
0.578 |
|
Show low-probability matches. |